Dennis Ross-Degnan

Dennis Ross-Degnan

Harvard University

H-index: 89

North America-United States

About Dennis Ross-Degnan

Dennis Ross-Degnan, With an exceptional h-index of 89 and a recent h-index of 45 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Pharmaceutical policy, health systems research, quality improvement.

His recent articles reflect a diverse array of research interests and contributions to the field:

Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use Among Commercially Insured Patients With Diabetes: A Pre–Post Study With a Control Group

Comparison of health care costs following sleeve gastrectomy versus Roux‐en‐Y gastric bypass among patients with type 2 diabetes

Acute Diabetes Complications After Transition to a Value-Based Medication Benefit

The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis

Effect of a national antibiotic stewardship intervention in China targeting carbapenem overuse: An interrupted time-series analysis

Acute care utilization and costs up to 4 years after index sleeve gastrectomy or Roux-en-Y gastric bypass: a national claims-based study

Who is first in line? Trends in use of poly (ADP-ribose) polymerase inhibitors (PARPi) among commercially insured women with ovarian cancer (2139)

The cost of a new therapy: How have PARP inhibitors changed costs for patients with ovarian cancer?(2251)

Dennis Ross-Degnan Information

University

Position

Harvard Medical School and Harvard Pilgrim Health Care Institute

Citations(all)

29440

Citations(since 2020)

9430

Cited By

25705

hIndex(all)

89

hIndex(since 2020)

45

i10Index(all)

268

i10Index(since 2020)

184

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Dennis Ross-Degnan Skills & Research Interests

Pharmaceutical policy

health systems research

quality improvement

Top articles of Dennis Ross-Degnan

Title

Journal

Author(s)

Publication Date

Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use Among Commercially Insured Patients With Diabetes: A Pre–Post Study With a Control Group

Annals of Internal Medicine

Laura F Garabedian

Fang Zhang

Rebecca Costa

Stephanie Argetsinger

Dennis Ross-Degnan

...

2024/4

Comparison of health care costs following sleeve gastrectomy versus Roux‐en‐Y gastric bypass among patients with type 2 diabetes

Obesity

Stephanie Argetsinger

Robert F LeCates

Fang Zhang

Dennis Ross‐Degnan

James F Wharam

...

2024/2/13

Acute Diabetes Complications After Transition to a Value-Based Medication Benefit

JAMA Health Forum

J Franklin Wharam

Stephanie Argetsinger

Matthew Lakoma

Fang Zhang

Dennis Ross-Degnan

2024/2/2

The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis

Masliyana Husin

Xin Rou Teh

Su Miin Ong

Yvonne Mei Fong Lim

Swee Hung Ang

...

2023/6/1

Effect of a national antibiotic stewardship intervention in China targeting carbapenem overuse: An interrupted time-series analysis

International Journal of Antimicrobial Agents

Sen Xu

Chenai Kitchen

Yang Liu

John Alimamy Kabba

Khezar Hayat

...

2023/10/1

Acute care utilization and costs up to 4 years after index sleeve gastrectomy or Roux-en-Y gastric bypass: a national claims-based study

Annals of surgery

Katherine Callaway Kim

Stephanie Argetsinger

James Frank Wharam

Fang Zhang

David E Arterburn

...

2023/1/1

Who is first in line? Trends in use of poly (ADP-ribose) polymerase inhibitors (PARPi) among commercially insured women with ovarian cancer (2139)

Gynecologic Oncology

Joseph Dottino

Stephanie Argetsinger

Rebecca Costa

Katharine Esselen

Dennis Ross-Degnan

...

2023/9/1

The cost of a new therapy: How have PARP inhibitors changed costs for patients with ovarian cancer?(2251)

Gynecologic Oncology

Katharine Esselen

Rebecca Costa

Stephanie Argetsinger

Joseph Dottino

Dennis Ross-Degnan

...

2023/9/1

Utilization and Spending With Preventive Drug Lists for Asthma Medications in High-Deductible Health Plans

JAMA Network Open

Anna D Sinaiko

Dennis Ross-Degnan

J Frank Wharam

Robert F LeCates

Ann Chen Wu

...

2023/8/1

15-OR: The Impact of Insulin Out-of-Pocket Caps among Commercially Insured Diabetes Patients

Diabetes

LAURA F GARABEDIAN

DENNIS ROSS-DEGNAN

REBECCA COSTA

STEPHANIE ARGETSINGER

FANG ZHANG

...

2023/6/20

Diabetes microvascular disease diagnosis and treatment after high-deductible health plan enrollment

Diabetes Care

J Frank Wharam

Jamie Wallace

Stephanie Argetsinger

Fang Zhang

Christine Y Lu

...

2022/8/1

High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder

The Journal of Clinical Psychiatry

Christine Y Lu

Fang Zhang

Jamie Wallace

Robert F LeCates

Alisa B Busch

...

2022/3/9

131-OR: Effect of a Value-Based Medication Benefit on Acute Preventable Diabetes Complications and Related Disparities

Diabetes

J WHARAM

Fang Zhang

Matthew Lakoma

Laura F Garabedian

Stephanie Argetsinger

...

2022/6/1

How does the effectiveness of strategies to improve healthcare provider practices in low-income and middle-income countries change after implementation? Secondary analysis of a …

Catherine Arsenault

Samantha Y Rowe

Dennis Ross-Degnan

David H Peters

Sanam Roder-DeWan

...

2022/2/1

Comparison of ambulatory health care costs and use associated with Roux-en-Y gastric bypass vs sleeve gastrectomy

JAMA Network Open

Kristina H Lewis

Stephanie Argetsinger

David E Arterburn

Jenna Clemenzi

Fang Zhang

...

2022/5/2

Financing strategies to facilitate access to high-cost anticancer drugs: a systematic review of the literature

Chanthawat Patikorn

Suthira Taychakhoonavudh

Rungpetch Sakulbumrungsil

Dennis Ross-Degnan

Puree Anantachoti

2022/9

The effectiveness of supervision strategies to improve health care provider practices in low-and middle-income countries: secondary analysis of a systematic review

Samantha Y Rowe

Dennis Ross-Degnan

David H Peters

Kathleen A Holloway

Alexander K Rowe

2022/1/6

Preventive Drug Lists and Controller Medication Use and Out-of-Pocket Costs for Patients with Asthma in High-Deductible Health Plans

A Galbraith

JF Wharam

D Ross-Degnan

F Zhang

AC Wu

...

2022/5

Evaluating Natural Experiments that Impact the Diabetes Epidemic: an Introduction to the NEXT-D3 Network

Karen R Siegel

Mohammed K Ali

Ronald T Ackermann

Bernard Black

Nathalie Huguet

...

2022/8

Use of palliative care among commercially insured patients with metastatic cancer between 2001 and 2016

JCO Oncology Practice

Alessandra Ferrario

Fang Zhang

Dennis Ross-Degnan

J Frank Wharam

Martha L Twaddle

...

2022/5

See List of Professors in Dennis Ross-Degnan University(Harvard University)